Unknown

Dataset Information

0

Drugs that offer a survival advantage for men with bone metastases resulting from castration-resistant prostate cancer: new and emerging treatment options.


ABSTRACT: A survival benefit has been demonstrated or is under investigation as the primary outcome among certain recently approved agents and investigational agents for men with metastatic castration-resistant prostate cancer that has spread to bone.

SUBMITTER: McCain J 

PROVIDER: S-EPMC3956387 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Drugs that offer a survival advantage for men with bone metastases resulting from castration-resistant prostate cancer: new and emerging treatment options.

McCain Jack J  

P & T : a peer-reviewed journal for formulary management 20140201 2


A survival benefit has been demonstrated or is under investigation as the primary outcome among certain recently approved agents and investigational agents for men with metastatic castration-resistant prostate cancer that has spread to bone. ...[more]

Similar Datasets

| S-EPMC3276755 | biostudies-literature
| S-EPMC5054655 | biostudies-literature
| S-EPMC8012826 | biostudies-literature
| S-EPMC10718079 | biostudies-literature
| S-EPMC3684567 | biostudies-literature
| S-EPMC5479409 | biostudies-literature
| S-EPMC3364443 | biostudies-literature
| S-EPMC4807885 | biostudies-literature
| S-EPMC2895780 | biostudies-literature
| S-EPMC3684034 | biostudies-literature